M&R Capital Management’s Edwards Lifesciences EW Stock Holding History

M&R Capital Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-480	Closed	-$38K	–	438
2020 Q3	$38K	Hold	480	–	–	0.01%	259
2020 Q2	$33K	Hold	480	–	–	0.01%	271
2020 Q1	$30K	Hold	480	–	–	0.01%	271
2019 Q4	$37K	Hold	480	–	–	0.01%	284
2019 Q3	$35K	Hold	480	–	–	0.01%	307
2019 Q2	$29K	Buy	+480	New	+$29K	0.01%	329
2018 Q1	–	Sell	-60	Closed	-$2.61K	–	528
2017 Q4	$2K	Hold	60	–	–	﹤0.01%	515
2017 Q3	$2K	Hold	60	–	–	﹤0.01%	525
2017 Q2	$2K	Hold	60	–	–	﹤0.01%	521
2017 Q1	$1K	Hold	60	–	–	﹤0.01%	536
2016 Q4	$1K	Hold	60	–	–	﹤0.01%	534
2016 Q3	$2K	Hold	60	–	–	﹤0.01%	509
2016 Q2	$1K	Buy	+60	New	+$2.05K	﹤0.01%	509

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

M&R Capital Management's EW Position: Q4 2020 in Review

M&R Capital Management sold out of Edwards Lifesciences (EW) in Q4 2020, closing a stake of 480 shares — an estimated $38K sold.

M&R Capital Management first reported a position in EW in Q2 2016 and held it in 13 quarters. The position peaked at $38K in Q3 2020. 1,160 funds tracked by Wall St. Rank hold EW as of Q4 2020.

M&R Capital Management reported no remaining Edwards Lifesciences position as of Q4 2020 after selling out during the quarter.
M&R Capital Management sold 480 Edwards Lifesciences shares in Q4 2020, an estimated $38K.
M&R Capital Management first reported a position in Edwards Lifesciences in Q2 2016 and held it in 13 quarters.
M&R Capital Management's Edwards Lifesciences position peaked at $38K in Q3 2020.
1,160 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2020.

Based on M&R Capital Management's 13F filing for Q4 2020, filed 5 Jan 2021.